Ibandronate Sodium Tablets 150 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ibandronate Sodium Tablets 150 mg, covering 2012-06-28 to 2012-06-28. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition [Phase 1]